Jin Yang Pharmaceutical Co. Ltd (007370) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.028x

Based on the latest financial reports, Jin Yang Pharmaceutical Co. Ltd (007370) has a cash flow conversion efficiency ratio of 0.028x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.53 Billion ≈ $3.07 Million USD) by net assets (₩159.98 Billion ≈ $108.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jin Yang Pharmaceutical Co. Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Jin Yang Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Jin Yang Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jin Yang Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jin Yang Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ocean Group JSC VN:OGC	0.070x
Union Corporation KO:000910	0.034x
EP Manufacturing Bhd KLSE:7773	0.169x
Medicamen Biotech Limited NSE:MEDICAMEQ	0.013x
Korea Ind KO:002140	0.119x
Chumpower Machinery Corp TWO:4575	0.030x
iCRAFT Co. Ltd KQ:052460	0.170x
Workhorse Group Inc NASDAQ:WKHS	-0.245x

Annual Cash Flow Conversion Efficiency for Jin Yang Pharmaceutical Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Jin Yang Pharmaceutical Co. Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Jin Yang Pharmaceutical Co. Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩159.86 Billion ≈ $108.33 Million	₩1.46 Billion ≈ $992.80K	0.009x	-91.41%
2024-12-31	₩119.88 Billion ≈ $81.24 Million	₩12.79 Billion ≈ $8.67 Million	0.107x	+12.02%
2023-12-31	₩89.58 Billion ≈ $60.71 Million	₩8.53 Billion ≈ $5.78 Million	0.095x	-0.78%
2022-12-31	₩77.58 Billion ≈ $52.57 Million	₩7.45 Billion ≈ $5.05 Million	0.096x	+218.24%
2021-12-31	₩65.32 Billion ≈ $44.26 Million	₩1.97 Billion ≈ $1.34 Million	0.030x	-77.63%
2020-12-31	₩46.31 Billion ≈ $31.38 Million	₩6.24 Billion ≈ $4.23 Million	0.135x	-18.33%
2019-12-31	₩43.67 Billion ≈ $29.59 Million	₩7.21 Billion ≈ $4.89 Million	0.165x	+555.78%
2018-12-31	₩42.05 Billion ≈ $28.50 Million	₩1.06 Billion ≈ $717.38K	0.025x	+208.08%
2017-12-31	₩42.38 Billion ≈ $28.72 Million	₩-987.16 Million ≈ $-668.99K	-0.023x	-8399.26%
2016-12-31	₩49.15 Billion ≈ $33.31 Million	₩-13.47 Million ≈ $-9.13K	0.000x	+99.41%
2015-12-31	₩59.18 Billion ≈ $40.10 Million	₩-2.76 Billion ≈ $-1.87 Million	-0.047x	+7.06%
2014-12-31	₩61.48 Billion ≈ $41.66 Million	₩-3.08 Billion ≈ $-2.09 Million	-0.050x	--

About Jin Yang Pharmaceutical Co. Ltd

KQ:007370 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$33.03 Million

₩48.74 Billion KRW

Market Cap Rank

#23479 Global

#1576 in Korea

Share Price

₩3945.00

Change (1 day)

-3.78%

52-Week Range

₩3870.00 - ₩6740.00

All Time High

₩9262.22